Ultromics Raises £10M in Series A Funding

Ultromics, a UK-based startup which uses AI to diagnose coronary heart disease, has raised £10 million in a Series A round. The investment was led by Oxford Sciences Innovation (OSI), with participation from Neptune, RT Ventures, GT Healthcare, Tanarra, Fushia, and angel investors Andre Crawford-Brunt and Dieter Spälti.

With heart disease affecting almost 50% of people over the age of 40 and the biggest cause of death globally Ultromics aims to significantly increase accuracy in the diagnosis of coronary artery disease using its AI technology. 

The investment will be used to bring the technology to market in the USA and make it available in the UK early 2019.

To read more, click here.